Analyst Research Report Snapshot


Aarti Drugs Ltd.






11 May 2015





Companies referenced:

Available for Immediate Download

Aarti Drugs Ltd. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Aarti Drugs Ltd. required for business and competitor intelligence needs - Intelligence on Aarti Drugs Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Aarti Drugs Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Aarti Drugs (ADL) is pharmaceutical company, engaged in the manufacturing of vitamins, anti-arthritis, anti-fungal, antibiotics and angiotensin converting enzyme (ACE) inhibitors. The company also manufactures anti-diabetics, anti-cholinergic, sedatives and anti-depressant drugs. ADL primarily operates in India, where it is headquartered in Mumbai. The company recorded revenues of INR9,699.4 million (approximately $161.4 million) in the fiscal year ended March 2014, an increase of 17.6% over 2013. The company's operating profit was INR1,182.5 million (approximately $19.7 million) in fiscal 2014, an increase of 25.3% over 2013. Its net profit was INR617.1 million (approximately $10.3 million) in fiscal 2014, an increase of 36.4% over 2013. Reasons to Purchase: - Gain understanding of Aarti Drugs Ltd. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Aarti Drugs Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Aarti Drugs Ltd. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.